Trade press release

Bringing Flexibility and Simplicity to Continuous Manufacturing.

July 10, 2024

GEA and its partners are leading the way toward smaller, more flexible continuous processing technologies that are transforming the future of pharmaceutical development and manufacturing. At this year’s ACHEMA trade experts from GEA — one of the world’s largest suppliers of systems and components to the food, beverage and pharmaceutical industries — highlighted how they’re advancing industrial manufacturing with groundbreaking technology and adapting processes for a better future.
ConsiGma® DB modules offer standalone continuous dosing and blending operations, either using a ribbon blender or a linear blender. (Photo: GEA)

ConsiGma® DB modules offer standalone continuous dosing and blending operations, either using a ribbon blender or a linear blender. (Photo: GEA)

To dispel the common myths that #GoingConti is overly complex and expensive, Hovione and GEA Pharma & Healthcare recently announced an industry first collaboration that holds great promise for the pharmaceutical manufacturing sector. Together, the two companies aim to significantly increase the adoption of continuous manufacturing by providing enhanced capacity, flexibility, standardized equipment, improved quality and increased efficiency.

Based on a successful customer-supplier relationship spanning several years, the collaboration combines GEA’s engineering expertise with Hovione's development and manufacturing experience. At the time, GEA Pharma & Healthcare’s Phillip Gabb, Strategic Business Director, Pharma Solid Dosage, noted: “Continuous manufacturing systems allow for leaner and risk-reduced development paths, leaner supply chains, increased built-in quality and, in general, manufacturing processes that are more flexible and less complex. In the context of this strategic collaboration, Hovione and GEA will combine their strengths to further advance the technology and contribute to the establishment of higher standards and new levels of market acceptance.”

For example, the ConsiGma® CDC flex (patent pending) has been designed as a truly versatile system that can operate seamlessly in both continuous and batch modes, offering both high and low throughput functionality.

With a focus on user-friendliness, the ConsiGma® range will be further augmented with new developments to simplify routine operations, introduce automated workflows, and Smart control interfaces. This will empower operators to streamline production processes.

“We believe that continuous tableting can offer significant benefits to our customers, not only by expediting time-to-market and reducing development and manufacturing costs but also by improving product quality and sustainability,” commented Filipe Gaspar, Vice President of Technology Intensification at Hovione. “Through our collaboration with GEA, we aim to revolutionize the continuous production of oral solid dosage forms, making the technology more accessible and efficient for pharma customers.”

#TalkingPharma

Dr. Michael Golek

CONTACT

Phone: +49 211 9136 1505

About GEA

A GEA é uma das maiores fornecedoras para a indústria de processamento de alimentos e para uma ampla variedade de outras indústrias que geraram receitas consolidadas de aproximadamente EUR 4,9 bilhões em 2019.

O grupo internacional de tecnologia é especializado em maquinaria e plantas, além de tecnologia e componentes para processamentos. A GEA fornece soluções de energia sustentável para processos de produção sofisticados em diversos mercados de usuários finais e oferece um portfólio abrangente de serviços. O grupo gera cerca de 70% da sua receita no setor de alimentos e bebidas, que desfruta de um crescimento sustentável a longo prazo. Desde 31 de dezembro de 2018, a empresa empregou mais de 18.500 pessoas em todo o mundo. A GEA é líder de mercado e tecnologia em suas áreas de negócios. A empresa está listada na bolsa alemã MDAX (G1A, WKN 660 200), no Índice STOXX® Europe 600 e nos Índices selecionados de Sustentabilidade Global MSCI. Maiores informações disponíveis na Internet em gea.com. Se você não quiser mais receber informações da GEA, por favor envie um e-mail para pr@gea.com.
Receba notícias da GEA

Mantenha-se atualizado com as inovações e histórias da GEA, se registrando para receber notícias sobre a GEA.

Entre em contato

Estamos aqui para ajudar! Com apenas poucos detalhes poderemos responder à sua pergunta.